• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病:神经系统受累的诊断与预后

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

作者信息

Siva A, Kantarci O H, Saip S, Altintas A, Hamuryudan V, Islak C, Koçer N, Yazici H

机构信息

Department of Neurology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey.

出版信息

J Neurol. 2001 Feb;248(2):95-103. doi: 10.1007/s004150170242.

DOI:10.1007/s004150170242
PMID:11284141
Abstract

This study was conducted to describe clinical and prognostic aspects of neurological involvement in Behçet's disease (BD). Patients referred for neurological evaluation fulfilled the criteria of the International Study Group for Behçet's Disease. We analyzed disability and survival by the Kaplan-Meier method, using Kurtzke's Extended Disability Status Scale (modified for BD) and the prognostic effect of demographic and clinical factors by Cox regression analysis. We studied 164 patients; of the 107 diagnostic neuroimaging studies: 72.1% showed parenchymal involvement, 11.7% venous sinus thrombosis (VST) and the others were normal. CSF studies were performed in 47 patients; all with inflammatory CSF findings (n = 18) had parenchymal involvement. An isolated increase in pressure was compatible with either VST or normal imaging. The final diagnoses were VST (12.2%), neuro-Behçet syndrome (NBS) (75.6%), isolated optic neuritis (0.6%), psycho-Behçet syndrome (0.6%), and indefinite (11%). VST and NBS were never diagnosed together. Ten years from onset of BD 45.1% (all NBS) reached a disability level of EDSS 6 or higher, and 95.7 +/- 2.1% of the patients were still alive. Having accompanying cerebellar symptoms at onset or a progressive course is unfavorable. Onset with headache or a diagnosis of VST is favorable. Two major neurological diagnoses in BD are NBS and VST. These are distinct in clinical, radiological, and prognostic aspects, hence suggesting a difference in pathogenesis.

摘要

本研究旨在描述白塞病(BD)神经受累的临床及预后情况。因神经方面问题接受评估的患者符合白塞病国际研究组的标准。我们采用Kaplan-Meier方法分析残疾情况和生存率,使用库尔茨克扩展残疾状态量表(针对BD进行了修改),并通过Cox回归分析人口统计学和临床因素的预后影响。我们研究了164例患者;在107项诊断性神经影像学研究中:72.1%显示实质受累,11.7%显示静脉窦血栓形成(VST),其他结果正常。对47例患者进行了脑脊液检查;所有脑脊液有炎症表现的患者(n = 18)均有实质受累。单纯压力升高与VST或影像学正常均相符。最终诊断为VST(12.2%)、神经白塞综合征(NBS)(75.6%)、孤立性视神经炎(0.6%)、精神白塞综合征(0.6%)以及不确定(11%)。VST和NBS从未同时被诊断。从BD发病起10年,45.1%(均为NBS)达到扩展残疾状态量表(EDSS)评分为6或更高的残疾水平,95.7±2.1%的患者仍存活。发病时伴有小脑症状或病程呈进行性是不利的。以头痛起病或诊断为VST是有利的。BD的两种主要神经诊断是NBS和VST。它们在临床、放射学和预后方面各不相同,因此提示发病机制存在差异。

相似文献

1
Behçet's disease: diagnostic and prognostic aspects of neurological involvement.白塞病:神经系统受累的诊断与预后
J Neurol. 2001 Feb;248(2):95-103. doi: 10.1007/s004150170242.
2
Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.白塞病神经表现的特征:突尼斯一项回顾性单中心研究
Clin Neurol Neurosurg. 2013 Oct;115(10):2015-8. doi: 10.1016/j.clineuro.2013.06.009. Epub 2013 Jul 3.
3
Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.Behcet 病神经系统受累的临床特征和疾病进程:HUVAC 经验。
Mult Scler Relat Disord. 2020 Feb;38:101512. doi: 10.1016/j.msard.2019.101512. Epub 2019 Nov 9.
4
Behçet's Syndrome and Nervous System Involvement.白塞综合征与神经系统受累。
Curr Neurol Neurosci Rep. 2018 May 23;18(7):35. doi: 10.1007/s11910-018-0843-5.
5
Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.白塞病神经受累的临床模式:200例患者的评估。神经白塞病研究组
Brain. 1999 Nov;122 ( Pt 11):2171-82. doi: 10.1093/brain/122.11.2171.
6
Parenchymal Neuro-Behçet's disease or Comorbid Behçet's disease with multiple sclerosis: A discriminative analysis of a complex clinical entity.实质型神经贝赫切特病或多发性硬化症合并贝赫切特病:一种复杂临床实体的鉴别分析。
Mult Scler Relat Disord. 2024 Jul;87:105684. doi: 10.1016/j.msard.2024.105684. Epub 2024 May 13.
7
Prognostic factors for relapse and poor outcome in neuro-Behçet's syndrome: results from a clinical long-term follow-up of a single centre.神经白塞病综合征复发及预后不良的预后因素:单中心临床长期随访结果
J Neurol. 2022 Apr;269(4):2046-2054. doi: 10.1007/s00415-021-10787-0. Epub 2021 Sep 4.
8
[Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature].[白塞病的神经系统受累。来自925例患者队列中的154例病例及文献综述]
Rev Neurol (Paris). 2006 Nov;162(11):1084-90. doi: 10.1016/s0035-3787(06)75121-9.
9
The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.白塞病中实质神经系统受累与后葡萄膜炎之间的关联。
Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):82-85. Epub 2016 Oct 7.
10
Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.磁共振成像表现与神经白塞病转归:预测因素。
Int J Rheum Dis. 2012 Dec;15(6):e142-9. doi: 10.1111/1756-185X.12013. Epub 2012 Oct 27.

引用本文的文献

1
Behçet's Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort.白塞氏综合征总体损伤指数在埃及成年人群中的表现及验证
Arch Rheumatol. 2024 Dec 12;39(4):607-616. doi: 10.46497/ArchRheumatol.2024.10893. eCollection 2024 Dec.
2
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.神经白塞病:临床诊断、生物标志物及免疫发病机制的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
3
Mimickers of nervous system involvement among patients with Behçet's syndrome.
白塞氏综合征患者神经系统受累的各种类似表现。
J Neurol. 2024 Oct;271(10):6903-6911. doi: 10.1007/s00415-024-12613-9. Epub 2024 Sep 4.
4
Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study.神经白塞病采用英夫利昔单抗治疗的长期预后:单中心回顾性研究。
Clin Rheumatol. 2024 Oct;43(10):3213-3221. doi: 10.1007/s10067-024-07118-9. Epub 2024 Aug 25.
5
Diffusion Tensor Imaging in Parenchymal Neuro-Behçet's Disease.实质型神经白塞病的扩散张量成像
Noro Psikiyatr Ars. 2024 Feb 27;61(1):39-46. doi: 10.29399/npa.28366. eCollection 2024.
6
Disease and Treatment-Specific Complications of Behçet Syndrome.贝切特综合征的疾病和治疗相关并发症。
Curr Rheumatol Rep. 2024 Jan;26(1):1-11. doi: 10.1007/s11926-023-01124-7. Epub 2023 Nov 23.
7
Vascular Involvement in Behcet's Disease: An Evaluation of 147 Cases and Literature Review.白塞病中的血管受累:147例病例评估及文献综述
Sisli Etfal Hastan Tıp Bul. 2023 Sep 29;57(3):380-386. doi: 10.14744/SEMB.2023.89083. eCollection 2023.
8
Neurologic manifestations of Behçet disease: rheumatology experience.贝赫切特病的神经系统表现:风湿病学经验。
Z Rheumatol. 2024 Feb;83(Suppl 1):200-205. doi: 10.1007/s00393-023-01436-0. Epub 2023 Oct 17.
9
Update on the Diagnosis of Behçet's Disease.白塞病诊断的最新进展
Diagnostics (Basel). 2022 Dec 23;13(1):41. doi: 10.3390/diagnostics13010041.
10
Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.白塞病风险变体 HLA-B51/ERAP1-Hap10 改变人类 CD8 T 细胞免疫。
Ann Rheum Dis. 2022 Nov;81(11):1603-1611. doi: 10.1136/ard-2022-222277. Epub 2022 Aug 3.